Regional Expression of CXCL12/CXCR4 in Liver and Hepatocellular Carcinoma and Cell‐cycle Variation during in vitro Differentiation

The CXCL12/CXCR4 system may be important in carcinoma. Expression of the a‐chemokine SDF‐lα (stromal cell derived factor‐lα)/CXCL12 mRNA is reduced in many carcinomas, yet its tissue protein expression may guide metastasis. Here we first compare the mRNA and protein expression of CXCL12 and its receptor CXCR4 in human liver, hepatocellular carcinoma, and malignant cell lines, and then assess cell cycle variation in CXCR4 expression. CXCR4 mRNA was present in most normal human tissues and malignant cell lines; it was only marginally reduced in hepatomas, while CXCL12 was markedly reduced, P<0.0001. Immuno‐histochemical staining of adjacent non‐malignant liver showed regional CXCR4 cytoplasmic and cell‐surface staining, limited to those hepatocytes around the central vein, a distribution resembling that of CXCL12. CXCL12 protein was not present in hepatocellular carcinoma cells in vivo, nor was cytoplasmic CXCR4 staining; nuclear CXCR4 protein expression in some malignant hepatocytes and CXCR4 staining of capillary endothelial cells around tumor cells were noted. In some malignant cell lines that had no CXCL12 on northern blots CXCL12 was weakly detectable by RT‐PCR or protein staining in the cytoplasm of a few cells. With a view to future manipulation of CXCL12/CXCR4 expression and growth we noted that in HT‐29 cells CXCR4 protein expression was less on confluent than on non‐confluent cells and varied during the cell cycle. Higher expression was associated most closely with the percentage of cells in the S‐phase and inversely with the percentage of cells in the G1‐phase. Treatment of HT‐29 cells with butyrate reduced CXCR4 cell surface expression and reduced the percentage of cells in S‐phase. In summary, CXCL12 protein expression parallels its mRNA, being markedly reduced in malignant cell lines and hepatomas; in liver, the regional distributions of CXCL12 and cytoplasmic CXCR4 are similar; finally, in HT‐29, CXCR4 expression correlates with the S‐phase of the cell cycle and is reduced during butyrate‐induced differentiation.

[1]  M. Honda,et al.  Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays , 2001, Hepatology.

[2]  G Mann,et al.  High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia , 2001, British journal of haematology.

[3]  J. Westwick,et al.  Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. , 1999, The Journal of clinical investigation.

[4]  M. Mori,et al.  Reduced expression of the CXC chemokine hIRH/SDF‐1α mRNA in hepatoma and digestive tract cancer , 1997, International journal of cancer.

[5]  M. Volin,et al.  Chemokine receptor CXCR4 expression in endothelium. , 1998, Biochemical and biophysical research communications.

[6]  C. Eaves,et al.  Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice , 2002 .

[7]  A. Koniski,et al.  Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. , 1999, Developmental biology.

[8]  C. Bucana,et al.  Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. , 1994, Cancer research.

[9]  J. Inazawa,et al.  Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. , 1995, Genomics.

[10]  R. Paroni,et al.  Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. , 1999, Blood.

[11]  K. Mimori,et al.  Loss of chemokine SDF-1alpha-mediated CXCR4 signalling and receptor internalization in human hepatoma cell line HepG2. , 2001, Cellular signalling.

[12]  S. Dudas,et al.  Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  M. Mori,et al.  Reduced expression of the CXCR4 receptor mRNA in hepatocellular carcinoma and lack of inducibility of its ligand alpha-chemokine hIRH/SDF1alpha/PBSF in vitro. , 1999, International journal of oncology.

[14]  H. Edmondson,et al.  Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies , 1954, Cancer.

[15]  B. Walker,et al.  Enhanced Inhibition of Human Immunodeficiency Virus Type 1 by Met-Stromal-Derived Factor 1β Correlates with Down-Modulation of CXCR4 , 1999, Journal of Virology.

[16]  D. Schadendorf,et al.  IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. , 1993, Journal of immunology.

[17]  I. Weinstein,et al.  Molecular cloning of TPAR1, a gene whose expression is repressed by the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA). , 1994, Experimental cell research.

[18]  E. Ebert,et al.  Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation , 2000, Current Biology.

[19]  J. Sodroski,et al.  The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.

[20]  A. Fauci,et al.  Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. , 1997, Journal of immunology.

[21]  M. Mori,et al.  CXCR4 mRNA expression in colon, esophageal and gastric cancers and hepatitis C infected liver. , 1999, International journal of oncology.

[22]  A. Foussat,et al.  Stromal cell-derived factor 1 (SDF-1) and antenatal human B cell lymphopoiesis: expression of SDF-1 by mesothelial cells and biliary ductal plate epithelial cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Le Bousse-Kerdilès,et al.  Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. , 2002, Blood.

[24]  T. Springer,et al.  Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Murphy,et al.  Molecular characterization of CXCR–4: A potential brain tumor‐associated gene , 1998, Journal of surgical oncology.

[26]  G. Murphy,et al.  CXCR‐4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells , 1998, Journal of surgical oncology.

[27]  Allen D. Delaney,et al.  Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen. , 1993, Genomics.

[28]  S. Dubinett,et al.  Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[29]  D. Pinsky,et al.  Hypoxic induction of interleukin-8 gene expression in human endothelial cells. , 1994, The Journal of clinical investigation.

[30]  T. Geiser,et al.  Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. , 1994, The Journal of biological chemistry.

[31]  M. Imamura,et al.  Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  A. Fauci,et al.  Cloning and analysis of the promoter region of CXCR4, a coreceptor for HIV-1 entry. , 1997, Journal of immunology.

[33]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[34]  S. Fujita,et al.  Enhancement of anti‐tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI‐1‐ligand chemokine and stromal cell–derived factor‐1αchemokine genes , 2001, International journal of cancer.

[35]  H. Augustin,et al.  Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. , 1998, Biochemical and biophysical research communications.

[36]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[37]  Bernhard Moser,et al.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.

[38]  白水 倫生.  Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene , 1995 .

[39]  D. Jaeck,et al.  Primary cultures of endothelial cells from the human liver sinusoid are permissive for human immunodeficiency virus type 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  K. Takenaka,et al.  Differential display and integrin alpha 6 messenger RNA overexpression in hepatocellular carcinoma , 1995, Hepatology.

[41]  L. Mayer,et al.  Inhibition of HIV‐1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-α , 1992 .

[42]  Kouji Matsushima,et al.  The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract , 1998, Nature.

[43]  F. Balkwill,et al.  Epithelial cancer cell migration: a role for chemokine receptors? , 2001, Cancer research.